Back to 
U.S. Bancorp
U.S. Bancorp
KPTI
16 quarters
Position history for U.S. Bancorp's holdings in Karyopharm Therapeutics Inc.
No. U.S. Bancorp exited its KPTI (Karyopharm Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 3,989 shares worth $22,000. U.S. Bancorp already held KPTI in its Q1 2019 13F, the earliest on record, and held it in 15 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$24,000
Total Shares Change
-4,035
Quarter-by-Quarter History
Other major holders of KPTI: Avoro Capital Advisors LLC, State Street Corp.